TEST BANK for Pharmacotherapeutics for Advanced Practice- A Practical Approach 5th Edition Arcangelo |ultimate guide |newest version 2024/25 A+

,Chapter 1 Issues for the Practitioner in Drug Therapy
YV YV YV YV YV YV YV YV




MULTIPLE CHOICE YV




1. Nurse practitioner prescriptive authority is regulated by:
YV YV YV YV YV YV



A. The National Council of State Boards of Nursing
YV YV YV YV YV YV YV



B. The U.S. Drug Enforcement Administration
YV YV YV YV



C. The State Board of Nursing for each state
YV YV YV YV YV YV YV



D. The State Board of Pharmacy
YV YV YV YV




ANS: C PTS: 1

2. Physician Assistant (PA) prescriptive authority is regulated by:
YV YV YV YV YV YV YV



A. The National Council of State Boards of Nursing
YV YV YV YV YV YV YV



B. The U.S. Drug Enforcement Administration
YV YV YV YV



C. The State Board of Nursing
YV YV YV YV



D. The State Board of Medical Examiners
YV YV YV YV YV




ANS: D PTS: 1

3. Clinical judgment in prescribing includes:
YV YV YV YV



A. Factoring in the cost to the patient of the medication prescribed
YV YV YV YV YV YV YV YV YV YV



B. Always prescribing the newest medication available for the disease process
YV YV YV YV YV YV YV YV YV



C. Handing out drug samples to poor patients
YV YV YV YV YV YV



D. Prescribing all generic medications to cut costs YV YV YV YV YV YV




ANS: A PTS: 1

4. Criteria for choosing an effective drug for a disorder include:
YV YV YV YV YV YV YV YV YV



A. Asking the patient what drug they think would work best for them
YV YV YV YV YV YV YV YV YV YV YV



B. Consulting nationally recognized guidelines for disease management
YV YV YV YV YV YV



C. Prescribing medications that are available as samples before writing a prescription
YV YV YV YV YV YV YV YV YV YV



D. Following U.S. Drug Enforcement Administration (DEA) guidelines fo
YV YV YV YV YV YV YV



rprescribing
V
Y




ANS: B PTS: 1

5. Nurse practitioner practice may thrive under health-care reform due to:
YV YV YV YV YV YV YV YV YV



A. The demonstrated ability of nurse practitioners to control costs and improve pati
YV YV YV YV YV YV YV YV YV YV YV



entoutcomes
V
Y



B. The fact that nurse practitioners will be able to practice independently
YV YV YV YV YV YV YV YV YV YV



C. The fact that nurse practitioners will have full reimbursement under health-
YV YV YV YV YV YV YV YV YV YV



carereform V
Y



D. The ability to shift accountability for Medicaid to the state level
YV YV YV YV YV YV YV YV YV YV




ANS: A PTS: 1

,Chapter 2.Pharmacokinetic Basis of Therapeutics and Pharmacodynamic
YV YV YV YV YV YV




MULTIPLE CHOICE YV




1. A patient's nutritional intake and lab work reflects hypoalbuminemia. This is crit
YV YV YV YV YV YV YV YV YV YV YV



icalto prescribing because:
V
Y YV YV



A. Distribution of drugs to target tissue may be affected YV YV YV YV YV YV YV YV



B. The solubility of the drug will not match the site of absorption
YV YV YV YV YV YV YV YV YV YV YV



C. There will be less free drug available to generate an effect
YV YV YV YV YV YV YV YV YV YV



D. Drugs bound to albumin are readily excreted by the kidney
YV YV YV YV YV YV YV YV YV




ANS: A PTS: 1

2. Drugs that have a significant first-pass effect:
YV YV YV YV YV YV



A. Must be given by the enteral (oral) route only
YV YV YV YV YV YV YV YV



B. Bypass the hepatic circulation YV YV YV



C. Are rapidly metabolized by the liver and may have little if any desired action
YV YV YV YV YV YV YV YV YV YV YV YV YV



D. Are converted by the liver to more active and fat-soluble forms
YV YV YV YV YV YV YV YV YV YV




ANS: C PTS: 1

3. The route of excretion of a volatile drug will likely be:
YV YV YV YV YV YV YV YV YV YV



A. The kidneys YV



B. The lungs YV



C. The bile and feces YV YV YV



D. The skin YV




ANS: B PTS: 1

4. Medroxyprogesterone (Depo Provera) is prescribed IM to create a storage reservoir of YV YV YV YV YV YV YV YV YV YV YV YV



thedrug. Storage reservoirs:
V
Y YV YV



A. Assure that the drug will reach its intended target tissue
YV YV YV YV YV YV YV YV YV



B. Are the reason for giving loading doses
YV YV YV YV YV YV



C. Increase the length of time a drug is available and active
YV YV YV YV YV YV YV YV YV YV



D. Are most common in collagen tissues
YV YV YV YV YV




ANS: C PTS: 1

5. The NP chooses to give cephalexin every 8 hours based on knowledge of the drug's:
YV YV YV YV YV YV YV YV YV YV YV YV YV YV



A. Propensity to go to the target receptor YV YV YV YV YV YV



B. Biological half-life YV



C. Pharmacodynamics
D. Safety and side effects YV YV YV




ANS: B PTS: 1

6. Azithromycin dosing requires the first day's dose be twice those of the other 4 da
YV YV YV YV YV YV YV YV YV YV YV YV YV YV



ys ofthe prescription. This is considered a loading dose. A loading dose:
YV V
Y YV YV YV YV YV YV YV YV YV YV



A. Rapidly achieves drug levels in the therapeutic range
YV YV YV YV YV YV YV



B. Requires four to five half-lives to attain YV YV YV YV YV YV



C. Is influenced by renal function
YV YV YV YV

, D. Is directly related to the drug circulating to the target tissues
YV YV YV YV YV YV YV YV YV YV




ANS: A PTS: 1

7. The point in time on the drug concentration curve that indicates the first sign of a therape
YV YV YV YV YV YV YV YV YV YV YV YV YV YV YV YV



uticeffect is the:
V
Y YV YV



A. Minimum adverse effect level YV YV YV



B. Peak of action YV YV



C. Onset of action YV YV



D. Therapeutic range YV




ANS: C PTS: 1

8. Phenytoin requires a trough level be drawn. Peak and trough levels are done:
YV YV YV YV YV YV YV YV YV YV YV YV



A. When the drug has a wide therapeutic range
YV YV YV YV YV YV YV



B. When the drug will be administered for a short time only
YV YV YV YV YV YV YV YV YV YV



C. When there is a high correlation between the dose and saturation of receptor sites
YV YV YV YV YV YV YV YV YV YV YV YV YV



D. To determine if a drug is in the therapeutic range
YV YV YV YV YV YV YV YV YV




ANS: D PTS: 1

9. A laboratory result indicates the peak level for a drug is above the minimum to
YV YV YV YV YV YV YV YV YV YV YV YV YV YV



xicconcentration. This means that the:
V
Y YV YV YV YV



A. Concentration will produce therapeutic effects YV YV YV YV



B. Concentration will produce an adverse response YV YV YV YV YV



C. Time between doses must be shortened
YV YV YV YV YV



D. Duration of action of the drug is too long YV YV YV YV YV YV YV YV




ANS: B PTS: 1

10. Drugs that are receptor agonists may demonstrate what property?
YV YV YV YV YV YV YV YV



A. Irreversible binding to the drug receptor site YV YV YV YV YV YV



B. Up-regulation with chronic use YV YV YV



C. Desensitization or down-regulation with continuous use YV YV YV YV YV



D. Inverse relationship between drug concentration and drug action
YV YV YV YV YV YV YV




ANS: C PTS: 1

11. Drugs that are receptor antagonists, such as beta blockers, may cause:
YV YV YV YV YV YV YV YV YV YV



A. Down-regulation of the drug receptor YV YV YV YV



B. An exaggerated response if abruptly discontinued
YV YV YV YV YV



C. Partial blockade of the effects of agonist drugs
YV YV YV YV YV YV YV



D. An exaggerated response to competitive drug agonists
YV YV YV YV YV YV




ANS: B PTS: 1

12. Factors that affect gastric drug absorption include:
YV YV YV YV YV YV



A. Liver enzyme activity YV YV



B. Protein-binding properties of the drug molecule YV YV YV YV YV



C. Lipid solubility of the drug
YV YV YV YV



D. Ability to chew and swallow YV YV YV YV




ANS: C PTS: 1